Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 182 | $100,108,792 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Jun 2023 16:34 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 20 Jun 2023 | Sale | 1,250 | 88.41 | 110,512 | D |
09 Jun 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Jun 2023 | Sale | 12,000 | 91.35 | 1,096,200 | D |
06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 30,506 | 89.8259 | 2,740,229 | D |
06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 7,064 | 88.3649 | 624,210 | D |
06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 30,609 | 87.7886 | 2,687,121 | D |
06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 1,600 | 90.6044 | 144,967 | D |
02 Jun 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 01 Jun 2023 | Sale | 5,000 | 86 | 430,000 | D |
18 May 2023 17:12 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 17 May 2023 | Sale | 1,250 | 88.66 | 110,825 | D |
18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 2,120 | 87.6739 | 185,869 | D |
18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 7,528 | 87.0163 | 655,059 | D |
18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 3,007 | 85.9012 | 258,305 | D |
18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 14,611 | 85.0089 | 1,242,065 | D |
18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 1,800 | 83.845 | 150,921 | D |
18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 934 | 83.1711 | 77,682 | D |
09 May 2023 17:02 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 May 2023 | Sale | 12,000 | 92.39 | 1,108,680 | D |
04 May 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 May 2023 | Sale | 5,000 | 82.71 | 413,550 | D |
20 Apr 2023 16:51 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 18 Apr 2023 | Sale | 30,000 | 82.024 | 2,460,720 | D |
18 Apr 2023 16:30 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 17 Apr 2023 | Sale | 1,250 | 81.05 | 101,312 | D |
11 Apr 2023 16:20 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 10 Apr 2023 | Sale | 12,000 | 78.21 | 938,520 | D |
05 Apr 2023 16:54 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 03 Apr 2023 | Sale | 500 | 74.05 | 37,025 | D |
05 Apr 2023 16:52 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 03 Apr 2023 | Sale | 5,000 | 75 | 375,000 | D |
05 Apr 2023 16:50 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Apr 2023 | Sale | 5,000 | 74.05 | 370,250 | D |
23 Mar 2023 16:55 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 21 Mar 2023 | Sale | 30,000 | 62.7444 | 1,882,332 | D |
21 Mar 2023 16:35 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 17 Mar 2023 | Sale | 1,250 | 64.03 | 80,038 | D |
10 Mar 2023 17:18 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Mar 2023 | Sale | 12,000 | 63.79 | 765,480 | D |
07 Mar 2023 16:53 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Mar 2023 | Sale | 5,000 | 63.84 | 319,200 | D |
02 Mar 2023 16:20 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Mar 2023 | Sale | 500 | 65.33 | 32,665 | D |
27 Feb 2023 16:34 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 23 Feb 2023 | Sale | 1,646 | 68.76 | 113,179 | D |
27 Feb 2023 16:32 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 23 Feb 2023 | Sale | 1,104 | 68.76 | 75,911 | D |
21 Feb 2023 16:22 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 17 Feb 2023 | Sale | 1,250 | 52.38 | 65,475 | D |
10 Feb 2023 17:00 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Feb 2023 | Sale | 12,000 | 54.45 | 653,400 | D |
06 Feb 2023 17:35 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Feb 2023 | Sale | 5,000 | 55.85 | 279,250 | D |
02 Feb 2023 16:15 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Feb 2023 | Sale | 500 | 52.61 | 26,305 | D |
31 Jan 2023 16:51 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 30 Jan 2023 | Sale | 883 | 52.76 | 46,587 | D |
31 Jan 2023 16:47 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 30 Jan 2023 | Sale | 883 | 52.76 | 46,587 | D |
25 Jan 2023 16:17 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 23 Jan 2023 | Sale | 2,955 | 51.58 | 152,419 | D |
25 Jan 2023 16:14 | APLS | Apellis Pharmaceuticals Inc | EISELE JEFFREY | Chief Development Officer | 23 Jan 2023 | Sale | 4,479 | 51.58 | 231,027 | D |
19 Jan 2023 16:55 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 17 Jan 2023 | Sale | 1,250 | 52.42 | 65,525 | D |
10 Jan 2023 20:07 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 09 Jan 2023 | Sale | 12,000 | 46.08 | 552,960 | D |
09 Jan 2023 19:02 | APLS | Apellis Pharmaceuticals Inc | GROSSI FEDERICO | Chief Medical Officer | 05 Jan 2023 | Sale | 2,500 | 48.79 | 121,975 | D |
05 Jan 2023 20:00 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Jan 2023 | Sale | 5,000 | 50.7 | 253,500 | D |
05 Jan 2023 19:40 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 03 Jan 2023 | Sale | 500 | 50.7 | 25,350 | D |
21 Dec 2022 16:13 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 19 Dec 2022 | Sale | 24,449 | 52.0697 | 1,273,052 | D |
21 Dec 2022 16:13 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 19 Dec 2022 | Sale | 3,751 | 51.9678 | 194,931 | D |
19 Dec 2022 16:37 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 15 Dec 2022 | Sale | 1,250 | 52.35 | 65,438 | D |
12 Dec 2022 16:28 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Dec 2022 | Sale | 12,000 | 47.5 | 570,000 | D |
07 Dec 2022 08:30 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 05 Dec 2022 | Sale | 5,000 | 50.38 | 251,900 | D |
02 Dec 2022 16:30 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Dec 2022 | Sale | 500 | 49.93 | 24,965 | D |
02 Dec 2022 16:30 | APLS | Apellis Pharmaceuticals Inc | GROSSI FEDERICO | Chief Medical Officer | 01 Dec 2022 | Sale | 2,500 | 49.93 | 124,825 | D |
17 Nov 2022 16:33 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 15 Nov 2022 | Sale | 1,250 | 48.01 | 60,012 | D |
10 Nov 2022 08:30 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Nov 2022 | Sale | 12,000 | 46.47 | 557,640 | D |
07 Nov 2022 16:19 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Nov 2022 | Sale | 5,000 | 58.54 | 292,700 | D |
03 Nov 2022 16:28 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Nov 2022 | Sale | 500 | 60.83 | 30,415 | D |
03 Nov 2022 16:27 | APLS | Apellis Pharmaceuticals Inc | GROSSI FEDERICO | Chief Medical Officer | 01 Nov 2022 | Sale | 2,500 | 60.83 | 152,075 | D |
17 Oct 2022 17:57 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 14 Oct 2022 | Sale | 1,250 | 59.31 | 74,138 | D |
11 Oct 2022 16:58 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 10 Oct 2022 | Sale | 12,000 | 57.5 | 690,000 | D |
05 Oct 2022 17:14 | APLS | Apellis Pharmaceuticals Inc | GROSSI FEDERICO | CHIEF MEDICAL OFFICER | 03 Oct 2022 | Sale | 2,500 | 66.69 | 166,725 | D |
05 Oct 2022 17:12 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Oct 2022 | Sale | 5,000 | 66.69 | 333,450 | D |
16 Sep 2022 16:03 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 15 Sep 2022 | Sale | 1,250 | 66 | 82,500 | D |
12 Sep 2022 16:52 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Sep 2022 | Sale | 12,000 | 63.98 | 767,760 | D |
08 Sep 2022 16:38 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 08 Sep 2022 | Sale | 15,000 | 65 | 975,000 | I |
07 Sep 2022 16:37 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 06 Sep 2022 | Sale | 5,000 | 60.38 | 301,900 | D |
02 Sep 2022 16:22 | APLS | Apellis Pharmaceuticals Inc | GROSSI FEDERICO | CHIEF MEDICAL OFFICER | 01 Sep 2022 | Sale | 2,500 | 60.3 | 150,750 | D |
18 Aug 2022 16:02 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 17 Aug 2022 | Sale | 5,000 | 69.5 | 347,500 | D |
16 Aug 2022 17:04 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 15 Aug 2022 | Sale | 12,500 | 69 | 862,500 | D |
16 Aug 2022 17:00 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 15 Aug 2022 | Sale | 1,250 | 67.21 | 84,012 | D |
12 Aug 2022 17:01 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 11 Aug 2022 | Sale | 12,500 | 67 | 837,500 | D |
12 Aug 2022 16:58 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 11 Aug 2022 | Sale | 5,000 | 67 | 335,000 | D |
12 Aug 2022 16:57 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 11 Aug 2022 | Sale | 30,000 | 65.63 | 1,968,900 | I |
09 Aug 2022 17:22 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 08 Aug 2022 | Sale | 12,500 | 65 | 812,500 | D |
09 Aug 2022 17:18 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Aug 2022 | Sale | 12,000 | 62.5 | 750,000 | D |
09 Aug 2022 17:16 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 08 Aug 2022 | Sale | 5,000 | 64.5 | 322,500 | D |
08 Aug 2022 16:02 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 04 Aug 2022 | Sale | 5,000 | 62 | 310,000 | D |
08 Aug 2022 16:02 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 04 Aug 2022 | Sale | 5,000 | 59.5 | 297,500 | D |
04 Aug 2022 18:40 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Aug 2022 | Sale | 5,000 | 56.43 | 282,150 | D |
02 Aug 2022 16:18 | APLS | Apellis Pharmaceuticals Inc | GROSSI FEDERICO | CHIEF MEDICAL OFFICER | 01 Aug 2022 | Sale | 2,500 | 55.99 | 139,975 | D |
28 Jul 2022 16:03 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 27 Jul 2022 | Sale | 5,000 | 57 | 285,000 | D |
21 Jul 2022 16:31 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Senior Vice President | 19 Jul 2022 | Sale | 5,000 | 56.42 | 282,100 | D |
18 Jul 2022 17:29 | APLS | Apellis Pharmaceuticals Inc | MACHIELS ALEC | Director | 15 Jul 2022 | Sale | 1,250 | 46.33 | 57,912 | D |
12 Jul 2022 17:55 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 11 Jul 2022 | Sale | 5,000 | 48.42 | 242,100 | D |
12 Jul 2022 16:04 | APLS | Apellis Pharmaceuticals Inc | DESCHATELETS PASCAL | Chief Scientific Officer | 08 Jul 2022 | Sale | 12,000 | 47.95 | 575,400 | D |
29 Jun 2022 16:18 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 27 Jun 2022 | Sale | 1,341 | 46.7881 | 62,743 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)